OMFS
Invesco Russell 2000 Dynamic Multifactor ETF
OMFS tracks an index of US small-cap stocks selected by a combination of five investment factors, which are weighted based on current macroeconomic conditions.
US
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 284.0 M
ASSETS UNDER MGMT
39 bp
EXPENSES
Fund Basics
| Inception date | Nov 08, 2017 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Quarterly |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| INDIVIOR PHARMACEUTICALS INC ORDINARY SH | 1.9 % |
| STERLING CONSTRUCTION CO | 1.8 % |
| ARGAN INC | 1.7 % |
| NEXTRACKER, INC. CLASS A | 1.6 % |
| ARROWHEAD PHARMACEUTICALS, INC. | 1.5 % |
| CREDO TECHNOLOGY GROUP HOLDING LTD. | 1.3 % |
| RAMBUS INC | 1.3 % |
| LAUREATE EDUCATION, INC. CLASS A | 1.2 % |
| INTERDIGITAL INC | 1.2 % |
| FIRSTCASH, INC. | 1.1 % |
Constituent Breakdown
| Number of holdings | 1104 |
| Herfindahl-Hirschman Index | 20 |
| Wgt avg mkt cap (mns) | $4,203 |
| Large cap (>$10bn) | 11.6% |
| Mid cap ($2-10bn) | 59.9% |
| Small cap (<$2bn) | 21.5% |
| Developed mkts. | 93.9% |
| Emerging mkts. | 0.2% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 89.0 % |
 |
BERMUDA | 1.6 % |
 |
BRITAIN | 1.0 % |
 |
CAYMAN ISLANDS | 0.8 % |
Historical Performance
Standardized Performance (as of 05/31/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 14.4% | 28.9% | 16.9% | 14.7% | 4.5% | -- | -- | 8.7% |
| Dividend Yield | 0.4% | 1.4% | 1.6% | 1.6% | 1.4% | -- | -- | 1.5% |
| Total Returns | 14.8% | 30.3% | 18.4% | 16.3% | 6.0% | -- | -- | 10.2% | Ann. Volatility | 18.5% | 17.6% | 20.7% | 20.6% | 21.5% | -- | -- | 25.4% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 1.16 | 60% |
| MSCI EAFE | 0.79 | 46% |
| MSCI Emg Mkts | 0.55 | 38% |
Liquidity Measures
| Avg. volume (000) | 18 |
| ADV traded (mns) | $1 |
| Turnover | 0.3% |
| Avg. Bid/Ask (% of price) | 0.11% |
Technical Indicators
| 30d moving avg. (EMA) | $51.12 |
| Relative strength (RSI) | 62 |
| MACD/Signal | 0.75/0.61 |
| Bollinger Bands (Upper/Lower) | $53.30/$49.32 |
| Short interest (% of AUM) | 0.1% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. OMFS |
Expenses vs. OMFS |
ALTAR Score™ vs. OMFS |
|---|---|---|---|---|
| RSSL | Global X Russell 2000 ETF | 49.0% | -31 bp | -0.9% |
| IWM | iShares Russell 2000 ETF | 47.9% | -20 bp | -1.0% |
| GSSC | Goldman Sachs Activebeta U.S. Small Cap Equity ETF | 45.0% | -19 bp | +0.4% |
| VTWO | Vanguard Russell 2000 ETF | 43.7% | -32 bp | -0.9% |
| PSC | Principal U.S. Small-Cap ETF | 42.5% | -1 bp | +0.6% |
| IWO | iShares Russell 2000 Growth ETF | 36.7% | -15 bp | -2.7% |
| IWN | iShares Russell 2000 Value ETF | 36.5% | -15 bp | +0.7% |
| VTWV | Vanguard Russell 2000 Value ETF | 36.0% | -29 bp | +0.9% |
| VIOO | Vanguard S&P Small-Cap 600 ETF | 35.9% | -32 bp | +2.3% |
| JPSE | JPMorgan Diversified Return U.S. Small Cap Equity ETF | 35.8% | -10 bp | +2.7% |
Risk and Returns: OMFS vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 6/30/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
3.9%
ALTAR SCORE™
25th
PERCENTILE
UNDERWEIGHT
ETFRC RATING
There are 1,398 funds in the US Equity category with an average
ALTAR Score™ of 5.3% and a standard deviation
of 2.1%. OMFS's ALTAR Score™ is approximately -0.7 standard
deviations above the category average. This places OMFS in the 25th percentile
among funds in the category.
Sell-Side Consensus
$60.53
PRICE TARGET
+14.3%
UPSIDE